One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   UAE Cardiovascular Devices Market

[ 英語タイトル ] UAE Cardiovascular Devices Market - Growth, Trends & Forecasts (2020 - 2025)

Product Code : MDHC0088758
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 80
Category : Healthcare and Pharmaceuticals
Study Area : United Arab Emirates
Report format : PDF
Sales price option (consumption tax not included)
Single User USD3250 / Question Form
5 User USD3750 / Question Form
Enterprise User USD6500 / Question Form
 - Abbott Laboratories
- Al Naghi Medical Co.
- Cardinal Health Inc.
- Atlas Medical LLC
- GE Healthcare
- W. L. Gore & Associates, Inc.
- Medtronic PLC
- Biotronik
- Siemens Healthineers AG
- Advanced Healthcare LLC

[Report Description]

The cardiovascular devices market is expected to show significant growth in UAE during the forecast period, 2020-2025. The key contributors to the market growth are the growing burden of cardiovascular diseases and technological advancements. Cardiovascular diseases are one of the leading causes of mortality and morbidity in the UAE. According to the study of Hamdan Medical Journal, 2018, approximately 22% of the cardiovascular deaths were accounted for acute myocardial infarction (AMI), 16% for cerebrovascular disease, 6% for ischaemic heart disease and 5% for hypertension. The sedentary lifestyle among the population is expected to add a burden. Hence, the importance of early diagnosis and treatment is rising thereby boosting the cardiovascular devices market growth in UAE.

Key Market Trends

Diagnostic and Monitoring Segment is Expected to show a Significant Growth Rate in the Cardiovascular Devices Market

Diagnostic and Monitoring segments include an electrocardiogram (ECG), remote cardiac monitoring, and others. An electrocardiogram is used for measuring the electrical activity of the heart to analyze if it's working properly or not. The technological advancements occurring in these devices is driving the growth. The Ministry of Health and Prevention (MoHAP), recently (2020) introduced AI-based device monitoring cardiac arrhythmia in the Arab Health 2020. It is a type of ECG that is made with an aim to curb heart diseases even before they occur. Furthermore, the prevalence of hypertension is also increasing. According to the Journal of Hypertension, 2017, the prevalence of hypertension in the Middle-east Countries was around 30%. Hence, the demand for diagnostic and monitoring devices in this market is expected to increase.

Competitive Landscape

The major players in the market are Abbott Laboratories, Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences, GE Healthcare, W. L. Gore & Associates, Inc., Medtronic PLC, Biotronik, Siemens Healthineers AG, and Canon Medical Systems Corporation.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Assumptions
1.2 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapid Technological Advancements
4.2.2 Increasing Burden of Cardiovascular Diseases
4.2.3 Increased Preference of Minimally Invasive Procedures
4.3 Market Restraints
4.3.1 Stringent Regulatory Policies
4.3.2 High Cost of Instruments and Procedures
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Device Type
5.1.1 Diagnostic and Monitoring Devices Electrocardiogram (ECG) Remote Cardiac Monitoring Other Diagnostic and Monitoring Devices
5.1.2 Therapeutic and Surgical Devices Cardiac Assist Devices Cardiac Rhythm Management Device Catheter Grafts Other Therapeutic and Surgical Devices

6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Al Naghi Medical Co.
6.1.3 Cardinal Health Inc.
6.1.4 Atlas Medical LLC
6.1.5 GE Healthcare
6.1.6 W. L. Gore & Associates, Inc.
6.1.7 Medtronic PLC
6.1.8 Biotronik
6.1.9 Siemens Healthineers AG
6.1.10 Advanced Healthcare LLC




Recommended reports